Drugs & Medications

Revolutionizing Depression Treatment: Novel Rapid-Acting Antidepressants & Emerging Drug Targets

by

Major depressive disorder (MDD) is a global health crisis affecting over 300 million people. While available antidepressants help some patients, treatment is far from satisfactory for many. Exciting research into rapid-acting agents like ketamine and psilocybin combined with exploration of novel drug targets finally offers real hope for transformational change in how depression is treated. …

Read more

Antidepressants for Cancer Treatment via Autophagy Modulation?

by

Antidepressants could potentially be repurposed as anticancer agents based on emerging evidence showing they can modulate autophagy—a process cancer cells rely on for growth and survival. Key Facts: Many antidepressants like SSRIs and TCAs have demonstrated anticancer effects in lab studies. Their mechanisms involve regulating autophagy, which plays a complex role in cancer development. Specific …

Read more

Running Therapy vs. Antidepressants: Efficacy for Depression, Anxiety, Health

by

New research finds that regular running is just as effective as antidepressants for treating depression and anxiety, and leads to better physical health outcomes. Key Facts: In a study of 141 patients, running therapy and antidepressant medication had comparable effects on rates of remission (no longer meeting diagnostic criteria) from depression/anxiety disorders. However, running led …

Read more

mGluR2/3 Inhibitors as Antidepressants: Targeting Glutamate Receptors in Depression

by

Depression affects over 300 million people globally. Current antidepressants have limited efficacy and slow onset of action. New research shows promise for compounds targeting metabotropic glutamate receptors 2 and 3 (mGluR2/3) as fast-acting antidepressants with fewer side effects. Key Facts: 1/3 of depressed patients are treatment-resistant with current antidepressants mGluR2/3 inhibitors show robust, rapid (within …

Read more

Optimizing Escitalopram (Lexapro) Dosage with CYP2C19 Enzyme Genetics & Body Weight

by

Researchers have made strides towards enabling personalized dosing for the commonly prescribed antidepressant escitalopram. Using robust clinical trial data, they developed an innovative population pharmacokinetics model that elucidates the impact of patient genetics and physiology. Key Facts: Model based on data from over 170 healthy Chinese adults receiving single escitalopram doses Identified CYP2C19 liver enzyme …

Read more

Prescription Drugs & Weight Gain: Which Medications Make People Fat?

by

Medications are meant to treat medical conditions and improve health, but some can have the unintended consequence of weight gain, which can then worsen other health risks. Understanding which medications tend to cause weight gain and the mechanisms behind this effect can help patients and doctors make informed treatment decisions. Key Facts: Medications for diabetes, …

Read more

Semaglutide: The Popular GLP-1 Receptor Agonist with Many Potential Medical Uses

by

Semaglutide is emerging as a wonder drug for management of various metabolic diseases. Originally approved for type 2 diabetes, this glucagon like peptide-1 (GLP-1) receptor agonist is now showing promise for treating obesity, non-alcoholic steatohepatitis (NASH), and neurodegenerative diseases like Alzheimer’s and Parkinson’s. Let’s explore the therapeutic potential of semaglutide and how it acts as …

Read more

MDPV Mechanisms of Action: Neurochemical Effects of the Synthetic Cathinone

by

Synthetic cathinones like MDPV emerged as drugs of abuse in the early 2010s, gaining notoriety for their powerful stimulant effects and association with bizarre intoxication and death. Despite legislation banning MDPV and its analogs, these substances continue circulating in the drug marketplace. Understanding the pharmacology of MDPV provides insight on its abuse liability, toxic effects, …

Read more

Low-Dose Amphetamine Restores Dopamine Transporters in Cocaine Addiction, Rat Study

by

Cocaine abuse leads to dysfunction of brain dopamine systems and the development of addiction. New research identifies changes in the dopamine transporter as a driving force underlying cocaine addiction, and points to a novel way to reverse these detrimental effects. Key Facts: Cocaine abuse caused the dopamine transporter to form larger complexes of multiple transporter …

Read more

Amphetamine Sensitization Alters Brain’s Reward Circuits in Humans (Study)

by

Researchers have found that repeated low doses of amphetamine can alter reward and motivation circuits in the human brain. The changes mirror what is seen in addiction and schizophrenia. Key Facts: Healthy volunteers received 4 doses of a low 20mg dose of amphetamine or placebo, spaced 2 days apart. Those getting amphetamine showed enhanced subjective …

Read more

+ Load more